Global Remdesivir (COVID-19) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Remdesivir (COVID-19) Industry Forecast” looks at past sales and reviews total world Remdesivir (COVID-19) sales in 2022, providing a comprehensive analysis by region and market sector of projected Remdesivir (COVID-19) sales for 2023 through 2029. With Remdesivir (COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Remdesivir (COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Remdesivir (COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Remdesivir (COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Remdesivir (COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Remdesivir (COVID-19) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Remdesivir (COVID-19).
The global Remdesivir (COVID-19) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Remdesivir (COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Remdesivir (COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Remdesivir (COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Remdesivir (COVID-19) players cover Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group and Inovio Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Remdesivir (COVID-19) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Remdesivir (COVID-19) market?
What factors are driving Remdesivir (COVID-19) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Remdesivir (COVID-19) market opportunities vary by end market size?
How does Remdesivir (COVID-19) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Remdesivir (COVID-19) Industry Forecast” looks at past sales and reviews total world Remdesivir (COVID-19) sales in 2022, providing a comprehensive analysis by region and market sector of projected Remdesivir (COVID-19) sales for 2023 through 2029. With Remdesivir (COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Remdesivir (COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Remdesivir (COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Remdesivir (COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Remdesivir (COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Remdesivir (COVID-19) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Remdesivir (COVID-19).
The global Remdesivir (COVID-19) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Remdesivir (COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Remdesivir (COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Remdesivir (COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Remdesivir (COVID-19) players cover Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group and Inovio Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Remdesivir (COVID-19) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 5mg
- 10mg
- 50mg
- 100mg
- Hospital
- Clinics
- Drug Store
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences
- Bright Gene
- Hainan Haiyao
- Kelun Pharma
- Hunan Warrant Pharmaceutical
- Borui Bio-Pharmaceutical
- Berry Global Group
- Inovio Pharmaceuticals
What is the 10-year outlook for the global Remdesivir (COVID-19) market?
What factors are driving Remdesivir (COVID-19) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Remdesivir (COVID-19) market opportunities vary by end market size?
How does Remdesivir (COVID-19) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Remdesivir (COVID-19) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Remdesivir (COVID-19) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Remdesivir (COVID-19) by Country/Region, 2018, 2022 & 2029
2.2 Remdesivir (COVID-19) Segment by Type
2.2.1 5mg
2.2.2 10mg
2.2.3 50mg
2.2.4 100mg
2.3 Remdesivir (COVID-19) Sales by Type
2.3.1 Global Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
2.3.2 Global Remdesivir (COVID-19) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Remdesivir (COVID-19) Sale Price by Type (2018-2023)
2.4 Remdesivir (COVID-19) Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Drug Store
2.4.4 Others
2.5 Remdesivir (COVID-19) Sales by Application
2.5.1 Global Remdesivir (COVID-19) Sale Market Share by Application (2018-2023)
2.5.2 Global Remdesivir (COVID-19) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Remdesivir (COVID-19) Sale Price by Application (2018-2023)
3 GLOBAL REMDESIVIR (COVID-19) BY COMPANY
3.1 Global Remdesivir (COVID-19) Breakdown Data by Company
3.1.1 Global Remdesivir (COVID-19) Annual Sales by Company (2018-2023)
3.1.2 Global Remdesivir (COVID-19) Sales Market Share by Company (2018-2023)
3.2 Global Remdesivir (COVID-19) Annual Revenue by Company (2018-2023)
3.2.1 Global Remdesivir (COVID-19) Revenue by Company (2018-2023)
3.2.2 Global Remdesivir (COVID-19) Revenue Market Share by Company (2018-2023)
3.3 Global Remdesivir (COVID-19) Sale Price by Company
3.4 Key Manufacturers Remdesivir (COVID-19) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Remdesivir (COVID-19) Product Location Distribution
3.4.2 Players Remdesivir (COVID-19) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR REMDESIVIR (COVID-19) BY GEOGRAPHIC REGION
4.1 World Historic Remdesivir (COVID-19) Market Size by Geographic Region (2018-2023)
4.1.1 Global Remdesivir (COVID-19) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Remdesivir (COVID-19) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Remdesivir (COVID-19) Market Size by Country/Region (2018-2023)
4.2.1 Global Remdesivir (COVID-19) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Remdesivir (COVID-19) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Remdesivir (COVID-19) Sales Growth
4.4 APAC Remdesivir (COVID-19) Sales Growth
4.5 Europe Remdesivir (COVID-19) Sales Growth
4.6 Middle East & Africa Remdesivir (COVID-19) Sales Growth
5 AMERICAS
5.1 Americas Remdesivir (COVID-19) Sales by Country
5.1.1 Americas Remdesivir (COVID-19) Sales by Country (2018-2023)
5.1.2 Americas Remdesivir (COVID-19) Revenue by Country (2018-2023)
5.2 Americas Remdesivir (COVID-19) Sales by Type
5.3 Americas Remdesivir (COVID-19) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Remdesivir (COVID-19) Sales by Region
6.1.1 APAC Remdesivir (COVID-19) Sales by Region (2018-2023)
6.1.2 APAC Remdesivir (COVID-19) Revenue by Region (2018-2023)
6.2 APAC Remdesivir (COVID-19) Sales by Type
6.3 APAC Remdesivir (COVID-19) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Remdesivir (COVID-19) by Country
7.1.1 Europe Remdesivir (COVID-19) Sales by Country (2018-2023)
7.1.2 Europe Remdesivir (COVID-19) Revenue by Country (2018-2023)
7.2 Europe Remdesivir (COVID-19) Sales by Type
7.3 Europe Remdesivir (COVID-19) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Remdesivir (COVID-19) by Country
8.1.1 Middle East & Africa Remdesivir (COVID-19) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2018-2023)
8.2 Middle East & Africa Remdesivir (COVID-19) Sales by Type
8.3 Middle East & Africa Remdesivir (COVID-19) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Remdesivir (COVID-19)
10.3 Manufacturing Process Analysis of Remdesivir (COVID-19)
10.4 Industry Chain Structure of Remdesivir (COVID-19)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Remdesivir (COVID-19) Distributors
11.3 Remdesivir (COVID-19) Customer
12 WORLD FORECAST REVIEW FOR REMDESIVIR (COVID-19) BY GEOGRAPHIC REGION
12.1 Global Remdesivir (COVID-19) Market Size Forecast by Region
12.1.1 Global Remdesivir (COVID-19) Forecast by Region (2024-2029)
12.1.2 Global Remdesivir (COVID-19) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Remdesivir (COVID-19) Forecast by Type
12.7 Global Remdesivir (COVID-19) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Remdesivir (COVID-19) Product Portfolios and Specifications
13.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Bright Gene
13.2.1 Bright Gene Company Information
13.2.2 Bright Gene Remdesivir (COVID-19) Product Portfolios and Specifications
13.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bright Gene Main Business Overview
13.2.5 Bright Gene Latest Developments
13.3 Hainan Haiyao
13.3.1 Hainan Haiyao Company Information
13.3.2 Hainan Haiyao Remdesivir (COVID-19) Product Portfolios and Specifications
13.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hainan Haiyao Main Business Overview
13.3.5 Hainan Haiyao Latest Developments
13.4 Kelun Pharma
13.4.1 Kelun Pharma Company Information
13.4.2 Kelun Pharma Remdesivir (COVID-19) Product Portfolios and Specifications
13.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kelun Pharma Main Business Overview
13.4.5 Kelun Pharma Latest Developments
13.5 Hunan Warrant Pharmaceutical
13.5.1 Hunan Warrant Pharmaceutical Company Information
13.5.2 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
13.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hunan Warrant Pharmaceutical Main Business Overview
13.5.5 Hunan Warrant Pharmaceutical Latest Developments
13.6 Borui Bio-Pharmaceutical
13.6.1 Borui Bio-Pharmaceutical Company Information
13.6.2 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
13.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Borui Bio-Pharmaceutical Main Business Overview
13.6.5 Borui Bio-Pharmaceutical Latest Developments
13.7 Berry Global Group
13.7.1 Berry Global Group Company Information
13.7.2 Berry Global Group Remdesivir (COVID-19) Product Portfolios and Specifications
13.7.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Berry Global Group Main Business Overview
13.7.5 Berry Global Group Latest Developments
13.8 Inovio Pharmaceuticals
13.8.1 Inovio Pharmaceuticals Company Information
13.8.2 Inovio Pharmaceuticals Remdesivir (COVID-19) Product Portfolios and Specifications
13.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Inovio Pharmaceuticals Main Business Overview
13.8.5 Inovio Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Remdesivir (COVID-19) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Remdesivir (COVID-19) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Remdesivir (COVID-19) by Country/Region, 2018, 2022 & 2029
2.2 Remdesivir (COVID-19) Segment by Type
2.2.1 5mg
2.2.2 10mg
2.2.3 50mg
2.2.4 100mg
2.3 Remdesivir (COVID-19) Sales by Type
2.3.1 Global Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
2.3.2 Global Remdesivir (COVID-19) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Remdesivir (COVID-19) Sale Price by Type (2018-2023)
2.4 Remdesivir (COVID-19) Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Drug Store
2.4.4 Others
2.5 Remdesivir (COVID-19) Sales by Application
2.5.1 Global Remdesivir (COVID-19) Sale Market Share by Application (2018-2023)
2.5.2 Global Remdesivir (COVID-19) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Remdesivir (COVID-19) Sale Price by Application (2018-2023)
3 GLOBAL REMDESIVIR (COVID-19) BY COMPANY
3.1 Global Remdesivir (COVID-19) Breakdown Data by Company
3.1.1 Global Remdesivir (COVID-19) Annual Sales by Company (2018-2023)
3.1.2 Global Remdesivir (COVID-19) Sales Market Share by Company (2018-2023)
3.2 Global Remdesivir (COVID-19) Annual Revenue by Company (2018-2023)
3.2.1 Global Remdesivir (COVID-19) Revenue by Company (2018-2023)
3.2.2 Global Remdesivir (COVID-19) Revenue Market Share by Company (2018-2023)
3.3 Global Remdesivir (COVID-19) Sale Price by Company
3.4 Key Manufacturers Remdesivir (COVID-19) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Remdesivir (COVID-19) Product Location Distribution
3.4.2 Players Remdesivir (COVID-19) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR REMDESIVIR (COVID-19) BY GEOGRAPHIC REGION
4.1 World Historic Remdesivir (COVID-19) Market Size by Geographic Region (2018-2023)
4.1.1 Global Remdesivir (COVID-19) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Remdesivir (COVID-19) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Remdesivir (COVID-19) Market Size by Country/Region (2018-2023)
4.2.1 Global Remdesivir (COVID-19) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Remdesivir (COVID-19) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Remdesivir (COVID-19) Sales Growth
4.4 APAC Remdesivir (COVID-19) Sales Growth
4.5 Europe Remdesivir (COVID-19) Sales Growth
4.6 Middle East & Africa Remdesivir (COVID-19) Sales Growth
5 AMERICAS
5.1 Americas Remdesivir (COVID-19) Sales by Country
5.1.1 Americas Remdesivir (COVID-19) Sales by Country (2018-2023)
5.1.2 Americas Remdesivir (COVID-19) Revenue by Country (2018-2023)
5.2 Americas Remdesivir (COVID-19) Sales by Type
5.3 Americas Remdesivir (COVID-19) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Remdesivir (COVID-19) Sales by Region
6.1.1 APAC Remdesivir (COVID-19) Sales by Region (2018-2023)
6.1.2 APAC Remdesivir (COVID-19) Revenue by Region (2018-2023)
6.2 APAC Remdesivir (COVID-19) Sales by Type
6.3 APAC Remdesivir (COVID-19) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Remdesivir (COVID-19) by Country
7.1.1 Europe Remdesivir (COVID-19) Sales by Country (2018-2023)
7.1.2 Europe Remdesivir (COVID-19) Revenue by Country (2018-2023)
7.2 Europe Remdesivir (COVID-19) Sales by Type
7.3 Europe Remdesivir (COVID-19) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Remdesivir (COVID-19) by Country
8.1.1 Middle East & Africa Remdesivir (COVID-19) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2018-2023)
8.2 Middle East & Africa Remdesivir (COVID-19) Sales by Type
8.3 Middle East & Africa Remdesivir (COVID-19) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Remdesivir (COVID-19)
10.3 Manufacturing Process Analysis of Remdesivir (COVID-19)
10.4 Industry Chain Structure of Remdesivir (COVID-19)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Remdesivir (COVID-19) Distributors
11.3 Remdesivir (COVID-19) Customer
12 WORLD FORECAST REVIEW FOR REMDESIVIR (COVID-19) BY GEOGRAPHIC REGION
12.1 Global Remdesivir (COVID-19) Market Size Forecast by Region
12.1.1 Global Remdesivir (COVID-19) Forecast by Region (2024-2029)
12.1.2 Global Remdesivir (COVID-19) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Remdesivir (COVID-19) Forecast by Type
12.7 Global Remdesivir (COVID-19) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Remdesivir (COVID-19) Product Portfolios and Specifications
13.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Bright Gene
13.2.1 Bright Gene Company Information
13.2.2 Bright Gene Remdesivir (COVID-19) Product Portfolios and Specifications
13.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bright Gene Main Business Overview
13.2.5 Bright Gene Latest Developments
13.3 Hainan Haiyao
13.3.1 Hainan Haiyao Company Information
13.3.2 Hainan Haiyao Remdesivir (COVID-19) Product Portfolios and Specifications
13.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hainan Haiyao Main Business Overview
13.3.5 Hainan Haiyao Latest Developments
13.4 Kelun Pharma
13.4.1 Kelun Pharma Company Information
13.4.2 Kelun Pharma Remdesivir (COVID-19) Product Portfolios and Specifications
13.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kelun Pharma Main Business Overview
13.4.5 Kelun Pharma Latest Developments
13.5 Hunan Warrant Pharmaceutical
13.5.1 Hunan Warrant Pharmaceutical Company Information
13.5.2 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
13.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hunan Warrant Pharmaceutical Main Business Overview
13.5.5 Hunan Warrant Pharmaceutical Latest Developments
13.6 Borui Bio-Pharmaceutical
13.6.1 Borui Bio-Pharmaceutical Company Information
13.6.2 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
13.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Borui Bio-Pharmaceutical Main Business Overview
13.6.5 Borui Bio-Pharmaceutical Latest Developments
13.7 Berry Global Group
13.7.1 Berry Global Group Company Information
13.7.2 Berry Global Group Remdesivir (COVID-19) Product Portfolios and Specifications
13.7.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Berry Global Group Main Business Overview
13.7.5 Berry Global Group Latest Developments
13.8 Inovio Pharmaceuticals
13.8.1 Inovio Pharmaceuticals Company Information
13.8.2 Inovio Pharmaceuticals Remdesivir (COVID-19) Product Portfolios and Specifications
13.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Inovio Pharmaceuticals Main Business Overview
13.8.5 Inovio Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Remdesivir (COVID-19) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Remdesivir (COVID-19) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5mg
Table 4. Major Players of 10mg
Table 5. Major Players of 50mg
Table 6. Major Players of 100mg
Table 7. Global Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 8. Global Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Table 9. Global Remdesivir (COVID-19) Revenue by Type (2018-2023) & ($ million)
Table 10. Global Remdesivir (COVID-19) Revenue Market Share by Type (2018-2023)
Table 11. Global Remdesivir (COVID-19) Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 13. Global Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Table 14. Global Remdesivir (COVID-19) Revenue by Application (2018-2023)
Table 15. Global Remdesivir (COVID-19) Revenue Market Share by Application (2018-2023)
Table 16. Global Remdesivir (COVID-19) Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Remdesivir (COVID-19) Sales by Company (2018-2023) & (K Units)
Table 18. Global Remdesivir (COVID-19) Sales Market Share by Company (2018-2023)
Table 19. Global Remdesivir (COVID-19) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Remdesivir (COVID-19) Revenue Market Share by Company (2018-2023)
Table 21. Global Remdesivir (COVID-19) Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Remdesivir (COVID-19) Producing Area Distribution and Sales Area
Table 23. Players Remdesivir (COVID-19) Products Offered
Table 24. Remdesivir (COVID-19) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Remdesivir (COVID-19) Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Remdesivir (COVID-19) Sales Market Share Geographic Region (2018-2023)
Table 29. Global Remdesivir (COVID-19) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Remdesivir (COVID-19) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Remdesivir (COVID-19) Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Remdesivir (COVID-19) Sales Market Share by Country/Region (2018-2023)
Table 33. Global Remdesivir (COVID-19) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Remdesivir (COVID-19) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Remdesivir (COVID-19) Sales by Country (2018-2023) & (K Units)
Table 36. Americas Remdesivir (COVID-19) Sales Market Share by Country (2018-2023)
Table 37. Americas Remdesivir (COVID-19) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Remdesivir (COVID-19) Revenue Market Share by Country (2018-2023)
Table 39. Americas Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 40. Americas Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 41. APAC Remdesivir (COVID-19) Sales by Region (2018-2023) & (K Units)
Table 42. APAC Remdesivir (COVID-19) Sales Market Share by Region (2018-2023)
Table 43. APAC Remdesivir (COVID-19) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Remdesivir (COVID-19) Revenue Market Share by Region (2018-2023)
Table 45. APAC Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 46. APAC Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 47. Europe Remdesivir (COVID-19) Sales by Country (2018-2023) & (K Units)
Table 48. Europe Remdesivir (COVID-19) Sales Market Share by Country (2018-2023)
Table 49. Europe Remdesivir (COVID-19) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Remdesivir (COVID-19) Revenue Market Share by Country (2018-2023)
Table 51. Europe Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 52. Europe Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Remdesivir (COVID-19) Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Remdesivir (COVID-19)
Table 60. Key Market Challenges & Risks of Remdesivir (COVID-19)
Table 61. Key Industry Trends of Remdesivir (COVID-19)
Table 62. Remdesivir (COVID-19) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Remdesivir (COVID-19) Distributors List
Table 65. Remdesivir (COVID-19) Customer List
Table 66. Global Remdesivir (COVID-19) Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Remdesivir (COVID-19) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Remdesivir (COVID-19) Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Remdesivir (COVID-19) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Remdesivir (COVID-19) Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Remdesivir (COVID-19) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Remdesivir (COVID-19) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Remdesivir (COVID-19) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Remdesivir (COVID-19) Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Remdesivir (COVID-19) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Remdesivir (COVID-19) Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Remdesivir (COVID-19) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Remdesivir (COVID-19) Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Remdesivir (COVID-19) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Gilead Sciences Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 81. Gilead Sciences Remdesivir (COVID-19) Product Portfolios and Specifications
Table 82. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Gilead Sciences Main Business
Table 84. Gilead Sciences Latest Developments
Table 85. Bright Gene Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 86. Bright Gene Remdesivir (COVID-19) Product Portfolios and Specifications
Table 87. Bright Gene Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bright Gene Main Business
Table 89. Bright Gene Latest Developments
Table 90. Hainan Haiyao Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 91. Hainan Haiyao Remdesivir (COVID-19) Product Portfolios and Specifications
Table 92. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hainan Haiyao Main Business
Table 94. Hainan Haiyao Latest Developments
Table 95. Kelun Pharma Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 96. Kelun Pharma Remdesivir (COVID-19) Product Portfolios and Specifications
Table 97. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Kelun Pharma Main Business
Table 99. Kelun Pharma Latest Developments
Table 100. Hunan Warrant Pharmaceutical Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 101. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
Table 102. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hunan Warrant Pharmaceutical Main Business
Table 104. Hunan Warrant Pharmaceutical Latest Developments
Table 105. Borui Bio-Pharmaceutical Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 106. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
Table 107. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Borui Bio-Pharmaceutical Main Business
Table 109. Borui Bio-Pharmaceutical Latest Developments
Table 110. Berry Global Group Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 111. Berry Global Group Remdesivir (COVID-19) Product Portfolios and Specifications
Table 112. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Berry Global Group Main Business
Table 114. Berry Global Group Latest Developments
Table 115. Inovio Pharmaceuticals Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 116. Inovio Pharmaceuticals Remdesivir (COVID-19) Product Portfolios and Specifications
Table 117. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Inovio Pharmaceuticals Main Business
Table 119. Inovio Pharmaceuticals Latest Developments
Table 1. Remdesivir (COVID-19) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Remdesivir (COVID-19) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5mg
Table 4. Major Players of 10mg
Table 5. Major Players of 50mg
Table 6. Major Players of 100mg
Table 7. Global Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 8. Global Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Table 9. Global Remdesivir (COVID-19) Revenue by Type (2018-2023) & ($ million)
Table 10. Global Remdesivir (COVID-19) Revenue Market Share by Type (2018-2023)
Table 11. Global Remdesivir (COVID-19) Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 13. Global Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Table 14. Global Remdesivir (COVID-19) Revenue by Application (2018-2023)
Table 15. Global Remdesivir (COVID-19) Revenue Market Share by Application (2018-2023)
Table 16. Global Remdesivir (COVID-19) Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Remdesivir (COVID-19) Sales by Company (2018-2023) & (K Units)
Table 18. Global Remdesivir (COVID-19) Sales Market Share by Company (2018-2023)
Table 19. Global Remdesivir (COVID-19) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Remdesivir (COVID-19) Revenue Market Share by Company (2018-2023)
Table 21. Global Remdesivir (COVID-19) Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Remdesivir (COVID-19) Producing Area Distribution and Sales Area
Table 23. Players Remdesivir (COVID-19) Products Offered
Table 24. Remdesivir (COVID-19) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Remdesivir (COVID-19) Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Remdesivir (COVID-19) Sales Market Share Geographic Region (2018-2023)
Table 29. Global Remdesivir (COVID-19) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Remdesivir (COVID-19) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Remdesivir (COVID-19) Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Remdesivir (COVID-19) Sales Market Share by Country/Region (2018-2023)
Table 33. Global Remdesivir (COVID-19) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Remdesivir (COVID-19) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Remdesivir (COVID-19) Sales by Country (2018-2023) & (K Units)
Table 36. Americas Remdesivir (COVID-19) Sales Market Share by Country (2018-2023)
Table 37. Americas Remdesivir (COVID-19) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Remdesivir (COVID-19) Revenue Market Share by Country (2018-2023)
Table 39. Americas Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 40. Americas Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 41. APAC Remdesivir (COVID-19) Sales by Region (2018-2023) & (K Units)
Table 42. APAC Remdesivir (COVID-19) Sales Market Share by Region (2018-2023)
Table 43. APAC Remdesivir (COVID-19) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Remdesivir (COVID-19) Revenue Market Share by Region (2018-2023)
Table 45. APAC Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 46. APAC Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 47. Europe Remdesivir (COVID-19) Sales by Country (2018-2023) & (K Units)
Table 48. Europe Remdesivir (COVID-19) Sales Market Share by Country (2018-2023)
Table 49. Europe Remdesivir (COVID-19) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Remdesivir (COVID-19) Revenue Market Share by Country (2018-2023)
Table 51. Europe Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 52. Europe Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Remdesivir (COVID-19) Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Remdesivir (COVID-19) Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Remdesivir (COVID-19) Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Remdesivir (COVID-19)
Table 60. Key Market Challenges & Risks of Remdesivir (COVID-19)
Table 61. Key Industry Trends of Remdesivir (COVID-19)
Table 62. Remdesivir (COVID-19) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Remdesivir (COVID-19) Distributors List
Table 65. Remdesivir (COVID-19) Customer List
Table 66. Global Remdesivir (COVID-19) Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Remdesivir (COVID-19) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Remdesivir (COVID-19) Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Remdesivir (COVID-19) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Remdesivir (COVID-19) Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Remdesivir (COVID-19) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Remdesivir (COVID-19) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Remdesivir (COVID-19) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Remdesivir (COVID-19) Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Remdesivir (COVID-19) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Remdesivir (COVID-19) Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Remdesivir (COVID-19) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Remdesivir (COVID-19) Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Remdesivir (COVID-19) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Gilead Sciences Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 81. Gilead Sciences Remdesivir (COVID-19) Product Portfolios and Specifications
Table 82. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Gilead Sciences Main Business
Table 84. Gilead Sciences Latest Developments
Table 85. Bright Gene Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 86. Bright Gene Remdesivir (COVID-19) Product Portfolios and Specifications
Table 87. Bright Gene Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bright Gene Main Business
Table 89. Bright Gene Latest Developments
Table 90. Hainan Haiyao Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 91. Hainan Haiyao Remdesivir (COVID-19) Product Portfolios and Specifications
Table 92. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hainan Haiyao Main Business
Table 94. Hainan Haiyao Latest Developments
Table 95. Kelun Pharma Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 96. Kelun Pharma Remdesivir (COVID-19) Product Portfolios and Specifications
Table 97. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Kelun Pharma Main Business
Table 99. Kelun Pharma Latest Developments
Table 100. Hunan Warrant Pharmaceutical Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 101. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
Table 102. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hunan Warrant Pharmaceutical Main Business
Table 104. Hunan Warrant Pharmaceutical Latest Developments
Table 105. Borui Bio-Pharmaceutical Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 106. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Portfolios and Specifications
Table 107. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Borui Bio-Pharmaceutical Main Business
Table 109. Borui Bio-Pharmaceutical Latest Developments
Table 110. Berry Global Group Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 111. Berry Global Group Remdesivir (COVID-19) Product Portfolios and Specifications
Table 112. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Berry Global Group Main Business
Table 114. Berry Global Group Latest Developments
Table 115. Inovio Pharmaceuticals Basic Information, Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 116. Inovio Pharmaceuticals Remdesivir (COVID-19) Product Portfolios and Specifications
Table 117. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Inovio Pharmaceuticals Main Business
Table 119. Inovio Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Remdesivir (COVID-19)
Figure 2. Remdesivir (COVID-19) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Remdesivir (COVID-19) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Remdesivir (COVID-19) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Remdesivir (COVID-19) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5mg
Figure 10. Product Picture of 10mg
Figure 11. Product Picture of 50mg
Figure 12. Product Picture of 100mg
Figure 13. Global Remdesivir (COVID-19) Sales Market Share by Type in 2022
Figure 14. Global Remdesivir (COVID-19) Revenue Market Share by Type (2018-2023)
Figure 15. Remdesivir (COVID-19) Consumed in Hospital
Figure 16. Global Remdesivir (COVID-19) Market: Hospital (2018-2023) & (K Units)
Figure 17. Remdesivir (COVID-19) Consumed in Clinics
Figure 18. Global Remdesivir (COVID-19) Market: Clinics (2018-2023) & (K Units)
Figure 19. Remdesivir (COVID-19) Consumed in Drug Store
Figure 20. Global Remdesivir (COVID-19) Market: Drug Store (2018-2023) & (K Units)
Figure 21. Remdesivir (COVID-19) Consumed in Others
Figure 22. Global Remdesivir (COVID-19) Market: Others (2018-2023) & (K Units)
Figure 23. Global Remdesivir (COVID-19) Sales Market Share by Application (2022)
Figure 24. Global Remdesivir (COVID-19) Revenue Market Share by Application in 2022
Figure 25. Remdesivir (COVID-19) Sales Market by Company in 2022 (K Units)
Figure 26. Global Remdesivir (COVID-19) Sales Market Share by Company in 2022
Figure 27. Remdesivir (COVID-19) Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Remdesivir (COVID-19) Revenue Market Share by Company in 2022
Figure 29. Global Remdesivir (COVID-19) Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Remdesivir (COVID-19) Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 32. Americas Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 33. APAC Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 34. APAC Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 35. Europe Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 36. Europe Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 39. Americas Remdesivir (COVID-19) Sales Market Share by Country in 2022
Figure 40. Americas Remdesivir (COVID-19) Revenue Market Share by Country in 2022
Figure 41. Americas Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 42. Americas Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 43. United States Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Remdesivir (COVID-19) Sales Market Share by Region in 2022
Figure 48. APAC Remdesivir (COVID-19) Revenue Market Share by Regions in 2022
Figure 49. APAC Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 50. APAC Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 51. China Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Remdesivir (COVID-19) Sales Market Share by Country in 2022
Figure 59. Europe Remdesivir (COVID-19) Revenue Market Share by Country in 2022
Figure 60. Europe Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 61. Europe Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 62. Germany Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 71. Egypt Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Remdesivir (COVID-19) in 2022
Figure 77. Manufacturing Process Analysis of Remdesivir (COVID-19)
Figure 78. Industry Chain Structure of Remdesivir (COVID-19)
Figure 79. Channels of Distribution
Figure 80. Global Remdesivir (COVID-19) Sales Market Forecast by Region (2024-2029)
Figure 81. Global Remdesivir (COVID-19) Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Remdesivir (COVID-19) Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Remdesivir (COVID-19) Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Remdesivir (COVID-19) Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Remdesivir (COVID-19) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Remdesivir (COVID-19)
Figure 2. Remdesivir (COVID-19) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Remdesivir (COVID-19) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Remdesivir (COVID-19) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Remdesivir (COVID-19) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5mg
Figure 10. Product Picture of 10mg
Figure 11. Product Picture of 50mg
Figure 12. Product Picture of 100mg
Figure 13. Global Remdesivir (COVID-19) Sales Market Share by Type in 2022
Figure 14. Global Remdesivir (COVID-19) Revenue Market Share by Type (2018-2023)
Figure 15. Remdesivir (COVID-19) Consumed in Hospital
Figure 16. Global Remdesivir (COVID-19) Market: Hospital (2018-2023) & (K Units)
Figure 17. Remdesivir (COVID-19) Consumed in Clinics
Figure 18. Global Remdesivir (COVID-19) Market: Clinics (2018-2023) & (K Units)
Figure 19. Remdesivir (COVID-19) Consumed in Drug Store
Figure 20. Global Remdesivir (COVID-19) Market: Drug Store (2018-2023) & (K Units)
Figure 21. Remdesivir (COVID-19) Consumed in Others
Figure 22. Global Remdesivir (COVID-19) Market: Others (2018-2023) & (K Units)
Figure 23. Global Remdesivir (COVID-19) Sales Market Share by Application (2022)
Figure 24. Global Remdesivir (COVID-19) Revenue Market Share by Application in 2022
Figure 25. Remdesivir (COVID-19) Sales Market by Company in 2022 (K Units)
Figure 26. Global Remdesivir (COVID-19) Sales Market Share by Company in 2022
Figure 27. Remdesivir (COVID-19) Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Remdesivir (COVID-19) Revenue Market Share by Company in 2022
Figure 29. Global Remdesivir (COVID-19) Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Remdesivir (COVID-19) Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 32. Americas Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 33. APAC Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 34. APAC Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 35. Europe Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 36. Europe Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Remdesivir (COVID-19) Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Remdesivir (COVID-19) Revenue 2018-2023 ($ Millions)
Figure 39. Americas Remdesivir (COVID-19) Sales Market Share by Country in 2022
Figure 40. Americas Remdesivir (COVID-19) Revenue Market Share by Country in 2022
Figure 41. Americas Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 42. Americas Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 43. United States Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Remdesivir (COVID-19) Sales Market Share by Region in 2022
Figure 48. APAC Remdesivir (COVID-19) Revenue Market Share by Regions in 2022
Figure 49. APAC Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 50. APAC Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 51. China Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Remdesivir (COVID-19) Sales Market Share by Country in 2022
Figure 59. Europe Remdesivir (COVID-19) Revenue Market Share by Country in 2022
Figure 60. Europe Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 61. Europe Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 62. Germany Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Application (2018-2023)
Figure 71. Egypt Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Remdesivir (COVID-19) Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Remdesivir (COVID-19) in 2022
Figure 77. Manufacturing Process Analysis of Remdesivir (COVID-19)
Figure 78. Industry Chain Structure of Remdesivir (COVID-19)
Figure 79. Channels of Distribution
Figure 80. Global Remdesivir (COVID-19) Sales Market Forecast by Region (2024-2029)
Figure 81. Global Remdesivir (COVID-19) Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Remdesivir (COVID-19) Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Remdesivir (COVID-19) Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Remdesivir (COVID-19) Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Remdesivir (COVID-19) Revenue Market Share Forecast by Application (2024-2029)
